You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 15, 2024

Drugs in MeSH Category Cytochrome P-450 CYP2C8 Inducers

✉ Email this page to a colleague

« Back to Dashboard

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Hikma	RIFAMPIN	rifampin	CAPSULE;ORAL	065028-002	Mar 14, 2001		DISCN	No	No	⤷ Subscribe	⤷ Subscribe				⤷ Subscribe
Lupin Pharms	RIFAMPIN	rifampin	CAPSULE;ORAL	090034-001	Aug 21, 2013	AB	RX	No	No	⤷ Subscribe	⤷ Subscribe				⤷ Subscribe
Hikma	RIFAMPIN	rifampin	CAPSULE;ORAL	065028-001	Mar 14, 2001		DISCN	No	No	⤷ Subscribe	⤷ Subscribe				⤷ Subscribe
Epic Pharma Llc	RIFAMPIN	rifampin	CAPSULE;ORAL	064150-001	May 28, 1997	AB	RX	No	No	⤷ Subscribe	⤷ Subscribe				⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.